Literature DB >> 3301384

Failure to demonstrate disruption of ultradian growth hormone rhythm and insulin secretion by dorsomedial hypothalamic nucleus lesions that cause reduced body weight, linear growth and food intake.

L L Bernardis, G S Tannenbaum.   

Abstract

Weanling male rats received bilateral electrolytic lesions in the dorsomedial hypothalamic nuclei (DMNL rats); sham-operated animals served as controls. At the end of a 39-day postoperative period DMNL rats were lighter and shorter than controls and also exhibited significant hypophagia. Their efficiency of food utilization (weight gained for the amount of food eaten) was normal, however. Subsequent determination of plasma growth hormone (GH) and insulin (IRI) levels every 15 min for 6-h periods from freely moving chronically cannulated rats showed no differences in pulsatile patterns and peaks of GH nor in plasma IRI levels between DMNL rats and controls. There was also no significant difference between mean 6-H GH and IRI concentrations between the two groups. The reduced body weight, length and food intake are apparently unrelated to the normal GH and IRI secretory patterns. In conjunction with previous data indicating normal somatomedin activity and normal responses to various homeostatic challenges, the data make a strong case for the argument that DMNL rats are not "growth-retarded". Rather, they are normal animals that are "scaled-down" to a smaller size with maintenance of normal homeostatic capacity. This has been hypothesized to be due to the existence in these animals of an "organismic" set point.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301384     DOI: 10.1007/BF00270690

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  21 in total

1.  The effect of dorsomedial hypothalamic nuclei lesions on body weight regulation.

Authors:  L L Bellinger; L L Bernardis; S Brooks
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

2.  Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: evidence for the existence of a growth hormone-releasing factor.

Authors:  R Eikelboom; G S Tannenbaum
Journal:  Endocrinology       Date:  1983-01       Impact factor: 4.736

3.  Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.

Authors:  G S Tannenbaum
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

4.  Feed efficiency in growth-retarded rats with ventromedial and dorsomedial hypothalamic lesions produced shortly after weaning.

Authors:  L L Bernardis; L L Bellinger
Journal:  Physiol Behav       Date:  1979-11

5.  Six-month follow-up in weanling rats with ventromedial and dorsomedial hypothalamic lesions: somatic, endocrine, and metabolic changes.

Authors:  L L Bernardis; J K Goldman; C Chlouverakis; L A Frohman
Journal:  J Neurosci Res       Date:  1975       Impact factor: 4.164

6.  Origin of endocrine-metabolic changes in the weanling rat ventromedial syndrome.

Authors:  L L Bernardis; J K Goldman
Journal:  J Neurosci Res       Date:  1976       Impact factor: 4.164

Review 7.  Ventromedial and dorsomedial hypothalamic syndromes in the weanling rat: is the "center" concept really outmoded?

Authors:  L L Bernardis
Journal:  Brain Res Bull       Date:  1985-06       Impact factor: 4.077

8.  Water regulation in weanling hypodipsic dorsomedial hypothalamic-lesioned rats.

Authors:  L L Bellinger; L L Bernardis
Journal:  Am J Physiol       Date:  1982-03

9.  The lateral hypothalamic syndrome: recovery of feeding and drinking after lateral hypothalamic lesions.

Authors:  P TEITELBAUM; A N EPSTEIN
Journal:  Psychol Rev       Date:  1962-03       Impact factor: 8.934

10.  Human pancreas GH-releasing factor analog restores high-amplitude GH pulses in CNS lesion-induced GH deficiency.

Authors:  G S Tannenbaum; R Eikelboom; N Ling
Journal:  Endocrinology       Date:  1983-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.